Sven Nylander
Impact in
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 29
- Hematology 16
- Platelet Disorders and Treatments 14
- Blood Coagulation and Thrombosis Mechanisms 5
- Co-authors
- Rainer Schulz (2 shared papers)Marco Cattaneo (4 shared papers)Hans Lennernäs (2 shared papers)A.‐L. Ungell (2 shared papers)Yochai Birnbaum (8 shared papers)Yumei Ye (8 shared papers)Timothy D. Warner (2 shared papers)Carl Whatling (1 shared paper)
- Journals
- Journal of Thrombosis and Haemostasis (6 papers)Thrombosis Research (5 papers)Journal of the American College of Cardiology (5 papers)Arteriosclerosis Thrombosis and Vascular Biology (5 papers)Cardiovascular Drugs and Therapy (4 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Sven Nylander
51 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 110
- Internal Medicine 407
- Cardiology and Cardiovascular Medicine 1.2k
- Physiology 204
- Hematology 350
- Pharmaceutical Science 170
Countries citing papers authored by Sven Nylander
This map shows the geographic impact of Sven Nylander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Nylander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Nylander more than expected).
Fields of papers citing papers by Sven Nylander
This network shows the impact of papers produced by Sven Nylander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Nylander. The network helps show where Sven Nylander may publish in the future.
Co-authors
The 25 scholars most cited alongside Sven Nylander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 241 | |
| 2 | 1998 | 196 | |
| 3 | 2014 | 192 | |
| 4 | 2011 | 180 | |
| 5 | 2013 | 152 | |
| 6 | 1997 | 134 | |
| 7 | 2013 | 127 | |
| 8 | 2012 | 104 | |
| 9 | 2014 | 103 | |
| 10 | 2016 | 89 | |
| 11 | 2015 | 86 | |
| 12 | 2020 | 80 | |
| 13 | 1999 | 73 | |
| 14 | 2016 | 69 | |
| 15 | 2015 | 64 | |
| 16 | 2015 | 54 | |
| 17 | 2016 | 45 | |
| 18 | 2003 | 45 | |
| 19 | 2015 | 44 | |
| 20 | 2004 | 43 |
About Sven Nylander
Sven Nylander is a scholar working on Cardiology and Cardiovascular Medicine, Hematology, Internal Medicine, Surgery and Physiology, having authored 52 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (29 papers), Platelet Disorders and Treatments (14 papers), Venous Thromboembolism Diagnosis and Management (12 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), Adenosine and Purinergic Signaling (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Internal Medicine (407 citations), Cardiology and Cardiovascular Medicine (1.2k citations), Physiology (204 citations), Hematology (350 citations) and Pharmaceutical Science (170 citations). Sven Nylander has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Rainer Schulz, Marco Cattaneo, Hans Lennernäs, A.‐L. Ungell, Yochai Birnbaum, Yumei Ye, Timothy D. Warner, Carl Whatling, Christer Mattsson and J.J.J. van Giezen. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Thrombosis Research, Journal of the American College of Cardiology, Arteriosclerosis Thrombosis and Vascular Biology and Cardiovascular Drugs and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.